| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |